Long Tail Secures Substantial Growth Investment from Eir Partners Capital
New investment will help to accelerate Long Tail’s leadership in AI-native health system utilization management and physician advisory
CHICAGO--(BUSINESS WIRE)--Long Tail (the “Company”), a leading provider of AI-native software and services for utilization management, physician advisory and denials and appeals workflows across hospitals, medical centers and health systems, today announced it has received a strategic investment from Eir Partners Capital (“Eir Partners” or the “Firm”). Terms of the transaction were not disclosed.
Since its founding in 2023, Long Tail has set out to modernize how hospitals and health systems navigate payer complexity. The Company targets utilization management, one of the most consequential and overlooked drivers of high-cost claim denials, via a data-driven platform that pairs proprietary payer intelligence with AI-powered automation. By harnessing insights from a growing network of providers and physicians, Long Tail delivers actionable payer intelligence that improves reimbursement outcomes, streamlines denial workflows, and reduces the cost of utilization and physician advisor programs.
The new investment from Eir Partners will play an integral role in further supporting the Company’s continued product innovation, expansion of its proprietary data network and scaling of its go-to-market capabilities to meet growing demand across health systems.
“We are thrilled to partner with Eir Partners and view their investment as a powerful endorsement of our vision, strategy and market leadership,” said Jeff Means, Chief Executive Officer and Co-Founder of Long Tail. “Their extensive expertise in healthcare technology and proven operator-led approach make them the ideal partner for our Company as we continue delivering measurable value to our customers. We are looking forward to a successful partnership.”
“Utilization management and physician advisory remains a complex and under tapped market with limited technology yet enormous impact on the financial viability of health systems. We have been searching for a partner to build a category leader in this space and believe that Long Tail will solve for the market’s needs during an accelerated growth period with our partnership. Jeff, Chris, Austin and team have built the foundation for an enormously impactful company for this next phase,” said Brett Carlson, Founder and Chief Executive Officer of Eir Partners.
About Long Tail
Long Tail’s technology-enabled services improve operational efficiency of healthcare operations. We help providers uncover the unpublished payor rules impacting their revenue to reduce initial denials and improve recovery of clinical denials. For more information, please visit www.longtailhealth.com.
About Eir Partners Capital
Eir Partners Capital is a Miami-based private equity company focused on healthcare technology and tech-enabled services. Founded in 2015, Eir has partnered with entrepreneurs and management teams to create scaled, strategically differentiated platforms across payer, provider, employer, and pharma technology sectors. The Firm’s hands-on approach combines operational insight with deep industry relationships to drive long-term value. Targeted stages of investment include growth equity through control buyouts and equity check sizes range from $40 - $150 million or larger with co-investments. For more information, please visit our website at www.eirpartners.com or our LinkedIn page.
Contacts
Long Tail
info@longtailhealth.com
Eir Partners Capital
Elizabeth Edwards
eedwards@profileadvisors.com
Eir Partners Raises $1 Billion for Healthcare Technology Deals
Eir Partners Capital, a Miami private-equity firm that invests in healthcare technology and tech-enabled services, closed its third fund at more than double the size of its predecessor.
PharmaForceIQ Acquires Aktana to Deliver Unparalleled Cross-Functional Engagement Impact for Pharma
MIAMI – January 7, 2026 – PharmaForceIQ has announced its acquisition of Aktana, aligning its cutting-edge digital orchestration platform with the industry’s premier AI-driven field Next-Best-Action (NBA) platform.
The strategic move creates the industry’s first optichannel-in-a-box solution for pharma companies – an end-to-end commercial customer engagement system that can go live in as little as 6–8 weeks. This becomes the most holistic solution available to unify brand and field strategy, drive executional alignment, and measure impact immediately. PharmaForceIQ’s modular, ML-powered agile platform and Aktana’s sophisticated AI core will be integrated to ensure long-term scalability and innovation across the entire combined platform.
The asset acquisition deepens PharmaForceIQ’s footprint significantly in the United States and brings the platform to even more markets in the LATAM, APAC, and EMEA regions. This expands its capabilities in field engagement, offering even deeper predictive insights to help field teams improve their work.
The field NBA platform is powered by Aktana’s proprietary Knowledge Nexus dataset – real-world insights on 85+ validated use cases drawn from 100M+ field suggestions made and 5,000+ tactics executed over twelve years of orchestration and field execution expertise. It has driven demonstrated impact, including:
- 36% NBRx lift demonstrated across clients.
- 19% sales performance increase by users following a competitor launch.
- 20 minutes per day saved per rep in manual planning and logging.
PharmaForceIQ’s Chief Executive and Strategy Officer, Hemal Somaiya said: “We’re thrilled to add these new capabilities to deepen our orchestration engine, making PharmaForceIQ the industry’s only end-to-end go-to-market customer engagement platform. We will scale our work even more quickly across clients and other global pharma companies, including making field teams even smarter and more effective alongside our existing features that improve marketing performance.”
Applying optichannel engagement strategies across both field and digital drives massive efficiency gains across the commercial function:
- 3x average script lift.
- A 22% increase in brand strategy adherence.
- An 80% increase in HCP engagement rates.
- 20-30% budget savings over traditional media buying models.
Derek Choy, PharmaForceIQ Head of Product and former Co-Founder and Chief Product Officer of Aktana, said: “I am excited to bring our pioneering Field Orchestration platform to PharmaForceIQ. This move will take our product to the next level, enabling best-in-class orchestration across both field and digital. Our unified platform helps teams understand their customers even more deeply, enabling them to predict, orchestrate, and measure personalized journeys across the right field, digital, and P2P channels.”
Aktana has made significant platform enhancements over the past 24 months. These include AI-powered communications planning, automated tactic optimization, and live strategic visibility to improve HCP journey design and execution. This sophisticated tech will now be boosted by white-glove partnership from a team that’s earned 100% client renewals.
Canaccord Genuity acted as the sole financial advisor on the transaction.
Find out more about how PharmaForceIQ’s AI-powered customer engagement platform can give you an unfair advantage across every channel at pharmaforceiq.com.
Eir Partners-Backed Machinify Acquires Performant Healthcare in $670M Take-Private Buyout
The Eir Partners backed company closes its second major acquisition in 2025 to expand its AI-powered operating system to a broader range of clients.
Dallas, TX and Palo Alto, CA - October 21, 2025
Machinify, a leading healthcare intelligence company with expertise across the payment continuum, today announced the close of its acquisition of Performant Healthcare, Inc. (Nasdaq: PHLT) for approximately $670 million. The deal expands Machinify’s AI-powered platform to reach a broader range of clients, including government programs, and accelerates its mission to simplify and modernize healthcare payments.
“We’re thrilled to bring Performant into Machinify with such highly complementary assets,” said David Pierre, CEO of Machinify. “Performant has built deep relationships in the government sector, which expands on Machinify’s strong and expanding presence with national and regional payers. Together, we can offer our clients the most complete, data-driven platform for ensuring every healthcare dollar is used effectively.”
Bringing together Performant’s deep audit and recovery expertise with Machinify’s advanced AI platform will enable the company to deliver faster, more accurate insights, further reduce administrative burden and unlock greater savings for health plans. The integration enhances Machinify’s ability to serve both commercial and government payers with end-to-end intelligence — spanning claim error detection, prevention, recovery, and coordination of benefits. Performant CEO Simeon Kohl will remain with the company, joining the Machinify leadership team.
“I’m excited to join forces with Machinify at such a pivotal moment for the industry,” said Simeon Kohl, CEO of Performant Healthcare. “By combining our deep expertise with Machinify’s AI platform, we’ll be able to deliver even greater value to our clients — streamlining the payment process, improving accuracy, and supporting better outcomes across the healthcare system.”
With the addition of Performant, Machinify now supports hundreds of millions of claims annually and delivers billions in savings through its unified AI and human-expertise model — helping clients reduce waste, improve provider relationships, and ensure accuracy from contracts to claims.
Performant stockholders voted to approve the transaction at the Company’s special meeting of stockholders on October 17, 2025.
As a result of the completed transaction, Performant’s shares will no longer be publicly traded on and will be delisted from Nasdaq, and the Company will now operate as a privately held entity.
About Machinify
Machinify is a leading healthcare intelligence company with expertise across the payment continuum, delivering unmatched value, transparency, and efficiency to health plans. Deployed by over 75 health plans, including many of the top 20, and representing more than 170 million lives, Machinify’s AI operating system, combined with proven expertise, untangles healthcare data to deliver industry-leading speed, quality, and accuracy. We’re reshaping healthcare payment through seamless intelligence. For more information about Machinify and its partners, visit www.machinify.com.
Gifthealth Is First to Serve 6M Patients via Direct-to-Patient Platform
Major milestone that proves direct-to-patient works at scale.
Columbus, OH and Sterling, VA - October 7, 2025
Gifthealth, the patient access solution that unifies the prescription journey from provider to patient, today announced it has now served more than six million patients through its direct-to-patient (DTP) platform.
As the first platform to deliver DTP at scale, Gifthealth’s Digi+Hub model merges the speed of digital pharmacy with the flexibility of hub services, eliminating friction, reducing delays, and ensuring more patients start and stay on therapy. With six million patient journeys completed, Gifthealth delivers proven, scalable experience that transforms direct-to-patient from concept into reality.
Gifthealth is URAC and NABP accredited, licensed in all 50 states and Puerto Rico, and integrated into the majority of EHR systems. Its Digi+Hub engages more than 175,000 prescribers and powers prescription access across a nationwide network.
“Nothing should stand in the way of better health,” said Chip Parkinson, CEO, Gifthealth. “Our experience serving six million patients proves that direct-to-patient works, not in theory, but at scale. Gifthealth is redefining the prescription journey as a seamless, patient-centered experience that connects manufacturers, prescribers, and patients in ways the traditional system never could.”
Gifthealth delivers an end-to-end prescription journey that is seamless, not fragmented: from initiation through fulfillment, financial navigation, refills, and adherence. By uniting technology and human touch, Gifthealth helps patients start therapy sooner, persist longer, and experience fewer barriers, all while providing manufacturers and providers with the insight and reliability they need.
“The Gifthealth partnership has been invaluable to us and our patients,” said Dr. Natalie Cosgrove, AdventHealth. “From the very first day, the program has exceeded our expectations and continues to expand over time. To quote one of our patients, ‘this experience is so much better!’”
About Gifthealth
Gifthealth is a patient access solution that unifies the prescription journey from provider to patient—combining access, fulfillment, and patient services into one frictionless, branded experience. Our Digi+Hub model merges digital pharmacy speed with flexible hub services, helping more patients get on therapy faster, stay on therapy longer, and deliver better outcomes for brands and providers alike. Gifthealth operates dispensing pharmacies and a nationwide partner network to deliver consistent on-therapy outcomes at scale.
Gifthealth + Occam Health: Transforming Patient Access at Scale
Uniting nationwide digital pharmacy automation with specialty hub expertise to set a new benchmark for U.S. biopharma partners
Columbus, OH and Sterling, VA – Sept. 2, 2025 - Gifthealth today announced its acquisition of Occam Health Services creating the first-of-its-kind digital pharmacy platform and patient access hub solution fundamentally shifting how biopharma companies accelerate access and value for patients.
Gifthealth is the nation’s largest direct-to-patient partner for manufacturers and a pioneer in digital-first brand experiences. Integrating with Occam’s high-touch, personalized model positions the combined company to cut through today’s fragmented, friction-filled patient journey.
Serving more than six million patients annually across 20 brands – including low-cost therapies at high volumes and lower-volume specialty and rare medicines – Gifthealth + Occam drives new patient access benchmarks:
- Dispense rates 50% higher than industry averages[1]
- Refill success 1.5 times national averages[2]
- Customer satisfaction scores >90% compared to 77% industry-wide[3]
- 95% delivered to doorstep within 1 day vs. 6 days[4]
The combined organization powers these outcomes with a single partner platform bringing life-science breakthroughs straight to patients with automated prescription routing, direct and partner pharmacy dispensing, real-time pricing transparency, and multi-channel patient engagement.
The Gifthealth solution is customizable to brand-specific business rules and replaces a patchwork of hub vendors. It activates when a prescriber selects the digital pharmacy from any electronic health record dropdown and routes each script to the lowest patient cost in-network option – either a Gifthealth dispensing pharmacy or pharmacy partner.
More than 175,000 prescribers across multiple specialties use the combined company platform to help their patients receive medicines faster and stay on therapy longer.
The new company will be led by a senior team, including Chip Parkinson, a healthcare innovation veteran with leadership roles in pharma, diagnostics, health plans, and Fortune 50 pharmacy benefit consulting.
“Gifthealth and Occam deliver a ready-now digital and human-touch solution built for manufacturers - one that works with established supply chain realities but can also challenge misaligned incentives that lead to high friction for patients,” said Parkinson, CEO of Gifthealth. “The combination arrives just as innovators confront a push for direct-to-patient pricing and consumers demanding dramatically improved patient journey and pharmacy experiences.”
Gifthealth is available to support biopharma brands in fifty states and Puerto Rico. To discuss how we can help your portfolio, contact maria.miller@gifthealth.com
About Gifthealth
Gifthealth is a digital pharmacy and access platform that streamlines prescription fulfillment, reduces total patient out-of-pocket, and improves persistence for biopharma brands and the clinics that serve them. Gifthealth operates dispensing pharmacies and a nationwide partner network to deliver consistent on-therapy outcomes.
About Occam Health Services
Occam Health Services goes beyond standard patient support services. Inspired by Occam's Razor - the idea that the simplest solution is often the best - we cut through healthcare complexity to deliver streamlined access and better outcomes. Our journey began with a vision to transform patient support through the perfect blend of innovative technology and human expertise.
About Eir Partners
Eir Partners Capital, LLC is a private equity company focused exclusively on healthcare technology and tech- enabled services. Eir combines its operational expertise with bottoms up thematic sourcing efforts to accelerate value creation. Since inception, Eir has completed transactions across payer, provider, employer and pharma tech, including leading industry names such as GiftHealth, PharmaForceIQ, Helpware, and ReviveHealth. Targeted stages of investment include growth equity through control buyouts and equity check sizes range from $25 - $100 million.
[1] IQVIA Institute Report. Understanding the Use of Medicines in the U.S. 2025. April 30, 2025.
[2] IQVIA PBL. June 2023 – May 2025. Persistence of commercially insured patients taking chronic medications at month 3.
[3] American Customer Satisfaction Index. 2024 Drugstores Satisfaction Benchmark, https://theacsi.org/industries/drugstores. Accessed 8/19/2025.
[4] URAC®. 2023 Specialty Pharmacy Performance Measurement. February 2024. Gifthealth internal analysis.
Agentai Partners with Leading Healthcare Investors to Transform Medical Billing for U.S. Providers
LOS ANGELES — August 20, 2025
AgentAI, the AI platform transforming the revenue cycle management (RCM) industry, today announced it has secured a significant growth investment co-led by Transformation Capital, a leading growth equity firm in digital health, and Eir Partners, a private equity firm focused on healthcare technology.
The new capital will accelerate AgentAI's strategy of acquiring small and medium-sized medical billing companies and integrating its proprietary AI technology to deliver superior results for their healthcare provider clients. The company's platform automates the majority of manual RCM tasks, shrinking a week-long billing cycle to a matter of hours, and dramatically improving financial outcomes for providers.
"AgentAI is addressing one of the most critical and inefficient areas in healthcare," said Mike Dixon, Managing Partner at Transformation Capital. "By automating high-friction RCM workflows – AgentAI has a proven track record of reducing billing errors and accelerating collections for specialty provider groups. We're thrilled to partner with Zorik and the AgentAI team to deliver a better billing experience for providers—so clinicians can spend more time with patients and less on practice operations."
"The RCM market is fragmented and ripe for technological disruption," said Brett Carlson, Managing Partner at Eir Partners. "AgentAI's strategy of acquiring smaller billing companies and supercharging their operations with a proprietary AI platform is incredibly compelling. They are building a new kind of RCM leader, and we are excited to support their aggressive growth and acquisition roadmap."
This investment will be used to enhance AgentAI's platform and expand its acquisition capacity nationwide. The platform has demonstrated significant RCM improvements for providers, including achieving ~99% clean-claim rates, accelerating provider payments by up to 40%, and reducing aged accounts receivable by nearly 75%.
"Partnering with firms of the caliber of Transformation Capital and EIR Partners, who collectively manage over $2.3 billion in assets, is a powerful endorsement of our vision and strategy," said Zorik Gordon, CEO of AgentAI. "This capital will allow us to accelerate our acquisition strategy, scale our technology, and bring same-day billing and unprecedented financial outcomes to even more healthcare providers across the country."
About AgentAI
AgentAI pairs advanced AI with seasoned billing specialists to deliver same-day revenue-cycle performance for practices, hospitals, and RCM companies. Through its acquisition program, AgentAI provides medical-billing owners with premium valuations and the opportunity to share in future growth by leveraging its industry-leading AI automation platform.
About Transformation Capital
Transformation Capital is a growth equity firm focused on investments in digital health and technology-enabled services companies. With over $1.6B in assets under management, the firm is dedicated to supporting innovative companies that are improving the healthcare system by lowering costs, improving access, and enhancing the quality of care.
About Eir Partners
Eir Partners is a private equity firm focused on investing in the healthcare technology and tech-enabled services sectors. The firm partners with exceptional management teams to build industry-leading companies that are driving innovation and efficiency in healthcare.
Eir Partners and New Mountain Capital Form Smarter Technologies Through Combination of Smarterdx, Thoughtful.ai, and Access Healthcare
Combined entity to generate more than $800 million of revenue, serving over 200 clients and over 60 hospital systems
Jeremy Delinsky appointed as Chief Executive Officer of Smarter Technologies
Creates next generation AI-powered leader in healthcare administration and revenue management through AI-powered automation and insights platform
MIAMI, FL - May 19, 2025
Eir Partners (“Eir”) and New Mountain Capital, LLC (“New Mountain”), today announced a definitive agreement to form Smarter Technologies, the automation and insights platform for healthcare efficiency, created through the strategic combination of portfolio companies SmarterDx, Thoughtful.ai, and Access Healthcare.
Eir and New Mountain have partnered with and provided strategic growth investments to each of these companies to drive and expand their expertise and capabilities in healthcare revenue management. As a combined entity, Smarter Technologies will bring together these unique strengths, footprints, and offerings to better automate health systems’ workflows and bolster their financial performance.
Smarter Technologies serves more than 200 clients, including more than 60 hospitals and health systems, and over 500,000 providers. The company processes more than 400 million transactions and manages over $200 billion in combined revenue annually.
Founded in 2020, SmarterDx is the leading provider of proprietary clinical AI for revenue integrity and care quality. Thoughtful.ai, also founded in 2020, is the leading AI-powered business and revenue cycle automation platform that helps improve the productivity, accuracy, and scalability of healthcare operations. Founded in 2011, Access Healthcare is a leading technology-enabled platform for revenue cycle management (RCM) and partners with some of the largest U.S.-based healthcare organizations to deliver leading revenue cycle operations.
Within an increasingly complex healthcare landscape, Smarter Technologies will offer one of the most comprehensive platforms in the industry. The company will be well-positioned to leverage its cutting-edge solutions to enhance health systems and hospitals’ operational efficiency, reduce administrative inefficiency, and enable providers to better focus on enhancing patient experiences.
The combined company will be led by Jeremy Delinsky as CEO. Mr. Delinsky is an Executive Advisor to New Mountain and an experienced healthcare and technology executive. Individual leaders across SmarterDx, Thoughtful.ai, and Access Healthcare will continue to oversee each respective business within Smarter Technologies.
“Amid rapid change in the healthcare sector, Smarter Technologies offers a unique, comprehensive, and modular platform that addresses hospitals’ and health systems’ growing need for better administrative and revenue management technologies and capabilities,” said Mr. Delinsky. “I look forward to working with New Mountain and the accomplished, experienced teams across each business to collaborate, share insights and capabilities, and identify ways to both strengthen our industry leadership and innovate to better serve our clients across the healthcare market.”
“The healthcare provider revenue crisis has reached a breaking point, and the need for a new approach has never been higher. Smarter Technologies is poised to bring radical transformation to the industry,” said Robert Musslewhite, who is joining the board of Smarter Technologies. “I look forward to collaborating with the New Mountain team, as well as Jeremy and the leadership team of Smarter Technologies to scale the next generation of automation solutions for the sector.”
“We identified the market leaders across the most important areas of agentic-AI, machine learning and clinical data, and large-scale automation in the three companies and are now combining them to create the innovation leader of the sector. We see enormous potential for growth and an opportunity to transform the industry,” said Matt Holt, Managing Director and President, Private Equity, at New Mountain Capital. “We look forward to working with Jeremy, as well as the teams from each of the companies, in one integrated effort to build the most important disruptor in the market that will scale the next generation of revenue cycle innovation across the ecosystem.”
About Eir Partners Capital
Eir Partners Capital, LLC ("Eir Partners") is a Miami-based private equity company focused exclusively on healthcare technology and tech-enabled services. Eir combines its operational expertise with bottoms up thematic sourcing efforts to accelerate value creation. Since inception, Eir has completed transactions across payor, provider, employer and pharma tech, including leading industry names such as Capta, GiftHealth, Helpware, Machinify, PharmaForceIQ, and ReviveHealth. Targeted stages of investment include growth equity through control buyouts and equity check sizes range from $25 - $125 million. Visit www.eirpartners.com.
About New Mountain Capital
New Mountain Capital is a New York-based investment firm that emphasizes business building and growth, rather than excessive risk, as it pursues long-term capital appreciation. The firm currently manages private equity, strategic equity, credit, and net lease real estate funds with over $55 billion in assets under management. New Mountain seeks out what it believes to be the highest quality growth leaders in carefully selected industry sectors and then works intensively with management to build the value of these companies. For more information, visit: www.newmountaincapital.com.
About Smarter Technologies
Smarter Technologies, the automation and insights platform for healthcare efficiency, is a leading AI-powered revenue management platform that combines proprietary clinical agents, human-in-the-loop AI Agents, clinical ontology, and global financial and administrative services that allow healthcare organizations the flexibility to automate the entirety of their administrative and financial workflows to optimize operational outcomes and drive better patient experiences. For more information, visit: www.smarter-technologies.com.
###
Contact
Eir Partners Capital
Brett Carlson, Founder and CEO
830 Brickell Plaza
Suite 3203
Miami, FL 33131
Eir Partners Announces Growth Investment in Porter
The Company will use proceeds to further innovate its care-at-home services, software, and technology to expand its offerings and continue to improve patient outcomes.
MIAMI, FL - March 13, 2025
Eir Partners ("Eir"), a middle market private equity firm focused on healthcare technology and tech-enabled services, today announced a growth investment in Porter, the only platform dedicated to connecting plan members with the resources, services, products, and education they need to live their best lives at home.
Porter is led by John Criswell, an experienced healthcare technology founder, who witnessed firsthand how healthcare system complexity negatively impacts the quality of care for members and patients of payors and providers. John created Porter to build a technology solution to simplify the healthcare maze.
Headquartered in Baltimore, Porter has distinguished itself as the only quality- and risk adjustment-focused care coordination program. Porter uses technology and AI to streamline care coordination, removing barriers to follow-up treatment, improving patient outcomes, and driving compliance for risk adjustment programs. Porter's technology and services reach across the U.S., helping members from diverse backgrounds with a wide range of health conditions.
"We are excited to announce the growth partnership between Porter and Eir," said Brett Carlson, Managing Partner of Eir Partners. "Porter is making a meaningful difference across its covered patient population of over two million by driving follow-up treatment, improving health outcomes, and elevating the member experience."
John Criswell, Founder, CEO, and Chairman of Porter, added "We are pleased to be partnering with Eir given their strong history of investing and scaling technology-enabled providers in the payor services market. This is an exciting inflection point for Porter. We are thrilled to continue driving value for our patients, customers, and clinicians, while also increasing investment into our technology and expanding our geographic footprint."
Eir Partners received legal counsel from McDermott Will and Emery LP.
About Porter
Porter combines the power of AI with the power of care. Porter is a leading healthcare IT and services platform for care and coverage coordination that optimizes outcomes and member experience. Porter delivers understanding, compassion, information, and peace of mind for consumers. Driven by robust AI analytics, Porter's Care Guide team helps the member navigate the healthcare delivery system, secures the right support for each member's specific needs, and directs Porter's team of expert clinicians to perform comprehensive in-home care, complete with lab and diagnostic testing. By coordinating the complexities of each unique care journey, Porter helps close the gaps with the largest impact on quality measures, total cost of care, risk adjustment, and member experience. Visit www.helloporter.com.
About Eir Partners
Eir Partners Capital, LLC ("Eir Partners") is a Miami-based private equity company focused exclusively on healthcare technology and tech-enabled services. Eir combines its operational expertise with bottoms up thematic sourcing efforts to accelerate value creation. Since inception, Eir has completed transactions across payor, provider, employer and pharma tech, including leading industry names such as Capta, GiftHealth, Helpware, Machinify, PharmaForceIQ, and ReviveHealth. Targeted stages of investment include growth equity through control buyouts and equity check sizes range from $25 - $125 million. Visit www.eirpartners.com.
###
Contact
Eir Partners Capital
Brett Carlson, Founder and CEO
830 Brickell Plaza
Suite 3203
Miami, FL 33131